hero patient
hero patient
real patient real patient
hero text

EGRIFTA SV™ reduces Hard Belly
(Excess Hard Abdominal Fat)


Ask your healthcare provider if
NEW EGRIFTA SV™ may be right for you

What is “Hard Belly”?

Hard Belly is a buildup of extra hard fat in the abdominal (belly) area. Hard Belly is different from regular fat.

Find out about Hard Belly
EGRIFTA SV™ is a newly FDA approved treatment* used to reduce Hard Belly (excess hard abdominal fat).

It has been proven to significantly reduce Hard Belly (excess hard abdominal fat).

Learn more
THERA patient support® provides personal service to help you make the most of therapy.

The Staff Nurses and Patient Care Coordinators are your go-to resources for everyday support.

See the benefits
EGRIFTA SV™ is not approved to reduce the health consequences of Hard Belly (excess hard abdominal fat).
*A newly approved strength of tesamorelin for injection with the same efficacy and safety of tesamorelin 1 mg/vial. The 2 mg/vial is more concentrated than the 1 mg/vial, and the recommended daily dose is 1.4 mg.